IRIS
MONDA, EMANUELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.205
AS - Asia 3.249
NA - Nord America 2.455
SA - Sud America 464
AF - Africa 53
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 1
Totale 12.436
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 4.906
US - Stati Uniti d'America 2.384
SG - Singapore 1.163
CN - Cina 676
VN - Vietnam 518
HK - Hong Kong 436
IT - Italia 408
BR - Brasile 386
IE - Irlanda 368
DE - Germania 168
KR - Corea 163
IN - India 108
GB - Regno Unito 107
AR - Argentina 36
BD - Bangladesh 36
JP - Giappone 36
CA - Canada 34
FI - Finlandia 33
FR - Francia 33
AT - Austria 30
MX - Messico 26
GR - Grecia 23
SE - Svezia 22
NL - Olanda 19
ZA - Sudafrica 18
EC - Ecuador 17
TR - Turchia 16
UA - Ucraina 16
CH - Svizzera 13
IQ - Iraq 13
MA - Marocco 11
PL - Polonia 11
ES - Italia 9
IR - Iran 9
PK - Pakistan 9
LT - Lituania 8
SA - Arabia Saudita 8
CZ - Repubblica Ceca 7
ID - Indonesia 7
NZ - Nuova Zelanda 7
PH - Filippine 7
EG - Egitto 6
IL - Israele 6
CO - Colombia 5
JO - Giordania 5
NP - Nepal 5
UZ - Uzbekistan 5
VE - Venezuela 5
CL - Cile 4
KZ - Kazakistan 4
PE - Perù 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
CR - Costa Rica 3
DZ - Algeria 3
ET - Etiopia 3
JM - Giamaica 3
PY - Paraguay 3
SN - Senegal 3
UY - Uruguay 3
AU - Australia 2
AZ - Azerbaigian 2
BE - Belgio 2
EE - Estonia 2
HU - Ungheria 2
KE - Kenya 2
KG - Kirghizistan 2
LB - Libano 2
LK - Sri Lanka 2
MT - Malta 2
OM - Oman 2
PA - Panama 2
PT - Portogallo 2
RO - Romania 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AL - Albania 1
BF - Burkina Faso 1
BW - Botswana 1
CG - Congo 1
CY - Cipro 1
DK - Danimarca 1
GH - Ghana 1
GT - Guatemala 1
LV - Lettonia 1
MD - Moldavia 1
MY - Malesia 1
NO - Norvegia 1
PS - Palestinian Territory 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TW - Taiwan 1
UG - Uganda 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 12.436
Salva come PNG Salva come JPEG
Città #
Moscow 1.833
Singapore 520
San Jose 437
Hong Kong 423
Santa Clara 419
Dublin 368
Chandler 189
Ashburn 179
Ho Chi Minh City 177
Hefei 173
Seoul 162
Hanoi 129
New York 112
Naples 74
Beijing 70
Bengaluru 67
Los Angeles 55
Princeton 49
Roxbury 49
The Dalles 49
Munich 47
Bremen 41
Cambridge 31
Dallas 31
Rome 31
North Bergen 30
Da Nang 29
São Paulo 28
Milan 25
Aversa 22
Council Bluffs 22
Haiphong 22
Frankfurt am Main 21
Jacksonville 20
Napoli 20
Nuremberg 20
Falkenstein 18
Medford 18
Turku 18
Marano Di Napoli 17
Vienna 16
Chicago 15
Des Moines 15
Atlanta 14
Biên Hòa 14
Orem 14
Toronto 14
Amsterdam 13
Caserta 13
Hyderabad 12
London 12
Brooklyn 11
Chennai 11
Dhaka 11
Guangzhou 11
Boardman 10
Brasília 10
Rio de Janeiro 10
Wilmington 10
Belo Horizonte 9
Curitiba 9
Johannesburg 9
Memphis 9
Salvador 9
San Giovanni In Fiore 9
Denver 8
Helsinki 8
Ninh Bình 8
Shanghai 8
Stockholm 8
Thái Nguyên 8
Tokyo 8
Turin 8
Baghdad 7
Fortaleza 7
Buenos Aires 6
Casalnuovo di Napoli 6
Guayaquil 6
Hải Dương 6
Lappeenranta 6
Montreal 6
Nanjing 6
Pozzuoli 6
Quito 6
San Francisco 6
Warsaw 6
Amman 5
Boston 5
Bắc Ninh 5
Cairo 5
Campinas 5
Changsha 5
Hai Bà Trưng 5
Hillsboro 5
Mexico City 5
Pagani 5
Phoenix 5
Pratteln 5
Seattle 5
Tashkent 5
Totale 6.549
Salva come PNG Salva come JPEG
Nome #
Diagnostic issues faced by a rare disease healthcare network during Covid-19 outbreak: data from the Campania Rare Disease Registry 205
The Risk of Sudden Unexpected Cardiac Death in Children: Epidemiology, Clinical Causes, and Prevention 181
Advanced Heart Failure in Special Population—Pediatric Age 176
Combined Effect of Mediterranean Diet and Aerobic Exercise on Weight Loss and Clinical Status in Obese Symptomatic Patients with Hypertrophic Cardiomyopathy 168
Cardiovascular Involvement in mtDNA Disease: Diagnosis, Management, and Therapeutic Options 165
Beyond cholesterol metabolism: The pleiotropic effects of proprotein convertase subtilisin/kexin type 9 (PCSK9). Genetics, mutations, expression, and perspective for long-term inhibition 159
Multimodality Imaging in Cardiomyopathies with Hypertrophic Phenotypes 158
Role of the orexin system on arousal, attention, feeding behaviour and sleep disorders 157
Diagnosis and Management of Cardiovascular Involvement in Friedreich Ataxia 157
Natural history of left ventricular hypertrophy in infants of diabetic mothers 154
Access-Site Crossover in Patients With Acute Coronary Syndrome Undergoing Invasive Management 152
Diagnosis and Management of Cardiovascular Involvement in Fabry Disease 152
Medical treatment of patients with hypertrophic cardiomyopathy: An overview of current and emerging therapy 151
Aortopathies in mouse models of Pompe, Fabry and Mucopolysaccharidosis IIIB lysosomal storage diseases 150
Clinical, Genetic, and Histological Characterization of Patients with Rare Neuromuscular and Mitochondrial Diseases Presenting with Different Cardiomyopathy Phenotypes 146
The Heart Muscle and Valve Involvement in Marfan Syndrome, Loeys-Dietz Syndromes, and Collagenopathies 146
Bisoprolol for treatment of symptomatic patients with obstructive hypertrophic cardiomyopathy. The BASIC (bisoprolol AS therapy in hypertrophic cardiomyopathy) study 145
Combined Clinical, Molecular, and Muscle Biopsy Approach to Unveil Prevalence and Clinical Features of Rare Neuromuscular and Mitochondrial Diseases in Patients With Cardiomyopathies 143
Effect of beta-blockers and angiotensin receptor blockers in reducing the aortic growth rate in children with bicuspid aortic valve-related aortopathy 136
Cardiovascular Involvement in Transthyretin Cardiac Amyloidosis 133
An atypical Aymé-Gripp phenotype detected by exome sequencing 133
Diagnosis and Management of Rare Cardiomyopathies in Adult and Paediatric Patients. A Position Paper of the Italian Society of Cardiology (SIC) and Italian Society of Paediatric Cardiology (SICP) 133
Aortic Root Diameter in Highly-Trained Competitive Athletes: Reference Values According to Sport and Prevalence of Aortic Enlargement 131
Aetiology and clinical manifestations of patients with non-dilated left ventricular cardiomyopathy 131
Prevalence and clinical significance of right ventricular pulmonary arterial uncoupling in cardiac amyloidosis 131
Natural History of Hypertrophic Cardiomyopathy in Noonan Syndrome With Multiple Lentigines 130
The Role of Genetic Testing in Patients with Heritable Thoracic Aortic Diseases 129
Low-Dose Ticagrelor in Patients With High Ischemic Risk and Previous Myocardial Infarction: A Multicenter Prospective Real-World Observational Study 127
Multidisciplinary In-Depth Investigation in a Young Athlete Suffering from Syncope Caused by Myocardial Bridge 126
Multimodality Imaging in Arrhythmogenic Left Ventricular Cardiomyopathy 125
Pathophysiology, Functional Assessment and Prognostic Implications of Nutritional Disorders in Systemic Amyloidosis 124
Clinical Manifestations of 22q11.2 Deletion Syndrome 124
Immune-Checkpoint Inhibitor-Related Myocarditis: Where We Are and Where We Will Go 123
A complex unit for a complex disease: The HCM-Family Unit 121
Cardiovascular Involvement in Fabry's Disease: New Advances in Diagnostic Strategies, Outcome Prediction and Management 121
Impact of GLA Variant Classification on the Estimated Prevalence of Fabry Disease: A Systematic Review and Meta-Analysis of Screening Studies 120
Patterns of Left Ventricular Remodelling in Children and Young Patients with Hypertrophic Cardiomyopathy 116
SYNERGISM OR COMPETITION BETWEEN ZINC AND CHROMIUM DIETARY LEVELS ON INSULIN ACTION MECHANISM. A METHOD TO INVESTIGATE 115
External validation of the increased wall thickness score for the diagnosis of cardiac amyloidosis 115
Global left ventricular myocardial work efficiency in heart failure patients with cardiac amyloidosis: Pathophysiological implications and role in differential diagnosis 115
Prevalence and Clinical Significance of Intraventricular Conduction Disturbances in Hospitalized Children 115
Effectiveness in the short-term of a novel nutraceutical for the management of hypercholesterolemia: an observational multicenter primary care experience 112
Resistive index of central retinal artery, aortic arterial stiffness and OCTA correlated parameters in the early stage of fabry disease 111
The Role of Echocardiography for the Clinical Diagnosis, Risk Stratification, and Management of Cardiac Amyloidosis 110
Left Ventricular Non-Compaction in Children: Aetiology and Diagnostic Criteria 110
Hypertrophic Cardiomyopathy in RASopathies: Diagnosis, Clinical Characteristics, Prognostic Implications, and Management 109
Severe Lymphatic Disorder and Multifocal Atrial Tachycardia Treated with Trametinib in a Patient with Noonan Syndrome and SOS1 Mutation 108
[Rare Diseases and epidemiology: an overlook at data from the Campania Region Rare Disease Registry (Southern Italy)] 108
Genotype-Phenotype Correlations in ATTR Amyloidosis: A Clinical Update 107
Prevalence and direct costs of patients with neuromyelitis optica: Data from Campania region in southern Italy 107
Thoracic Aortic Dilation: Implications for Physical Activity and Sport Participation 106
Yield and clinical significance of genetic screening in elite and amateur athletes 106
Targeted Therapies in Pediatric and Adult Patients With Hypertrophic Heart Disease: From Molecular Pathophysiology to Personalized Medicine 105
Amyloid Cardiomyopathies: Clinical, Diagnostic, and Therapeutic Aspects 105
Artificial intelligence for left ventricular hypertrophy detection and differentiation on echocardiography, cardiac magnetic resonance and cardiac computed tomography: A systematic review 102
Lipoprotein(a): a genetic marker for cardiovascular disease and target for emerging therapies 100
Clinical characteristics and outcome of end stage hypertrophic cardiomyopathy: Role of age and heart failure phenotypes 98
The Role of New Imaging Technologies in the Diagnosis of Cardiac Amyloidosis 98
Clinical pathway on pediatric cardiomyopathies: A genetic testing strategy proposed by the Italian Society of Pediatric Cardiology 97
Prevalence and clinical significance of red flags in patients with hypertrophic cardiomyopathy 97
Beta-blockers in heart failure prognosis: Lessons learned by MECKI Score Group papers 97
Athlete’s Heart: A Cardiovascular Step-By-Step Multimodality Approach 96
Diagnosis of Fabry Disease in a Patient with a Surgically Repaired Congenital Heart Defect: When Clinical History and Genetics Make the Difference 96
Treatment options for hypertrophic obstructive cardiomyopathy: a patient-centric review 95
Prediction of incident atrial fibrillation in hypertrophic cardiomyopathy 93
Orexin system: Network multi-tasking 93
ECG analysis in patients with acute coronary syndrome undergoing invasive management: rationale and design of the electrocardiography sub-study of the MATRIX trial 93
An Overview of Molecular Mechanisms in Fabry Disease 93
Potential role of imaging markers in predicting future disease expression of arrhythmogenic cardiomyopathy 92
Hypertrophic cardiomyopathy: prevalence of disease-specific red flags 92
Clinical manifestation of patients with Fabry disease and R356W GLA variant 91
Hypertrophic Cardiomyopathy in Children: Pathophysiology, Diagnosis, and Treatment of Non-sarcomeric Causes 89
Prevalence of Pathogenic Variants in Cardiomyopathy-Associated Genes in Acute Myocarditis 88
A Roadmap to Predict Adverse Outcome in Fabry Disease 88
Unexplained sudden cardiac arrest in children: clinical and genetic characteristics of survivors 88
The role of genetic testing in Marfan syndrome 88
Genetic evaluation in athletes and cascade family screening: reply 87
Rare Cardiovascular Diseases: From Genetics to Personalized Medicine 87
Impact of Regular Physical Activity on Aortic Diameter Progression in Paediatric Patients with Bicuspid Aortic Valve 85
Clinical significance of family history and bicuspid aortic valve in children and young adult patients with Marfan syndrome 83
Current Management of Transition and Multidisciplinary Care of Patients with Inherited and Rare Cardiomyopathies in Europe: Results of the European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart (ERN GUARD-HEART) 82
Molecular Basis of Inflammation in the Pathogenesis of Cardiomyopathies 82
Sport activity in patients with cardiomyopathies: a review 81
Prognostic Implications of Declining Hemoglobin Content in Patients Hospitalized With Acute Coronary Syndromes 81
Left ventricular rotational mechanics in cardiac amyloidosis - reply 81
Implantable cardioverter defibrillator in hypertrophic cardiomyopathy: Time to avoid unnecessary procedure 80
From the phenotype to precision medicine: an update on the cardiomyopathies diagnostic workflow 77
Is There a Role for Genetic Testing in Patients With Myocarditis? 77
Prediction of radial crossover in acute coronary syndromes: Derivation and validation of the MATRIX score 77
Modified Body Mass Index as a Novel Nutritional and Prognostic Marker in Patients with Cardiac Amyloidosis 76
Rare case of Kawasaki disease with cardiac tamponade and giant coronary artery aneurysms 76
Editorial: Paediatric Cardiomyopathies 76
Hypertrophic Cardiomyopathy-Current Challenges and Future Perspectives 75
Sudden cardiac death risk prediction in Fabry disease: How many strings do we have on our bow? 75
Real-world candidacy to mavacamten in a contemporary hypertrophic obstructive cardiomyopathy population 74
Prevalence and clinical implications of hyperhomocysteinaemia in patients with hypertrophic cardiomyopathy and MTHFR C6777T polymorphism 74
The heart in RASopathies 73
The Prognostic Role of Pulmonary Arterial Elastance in Patients Undergoing Left Ventricular Assist Device Implantation: A Pilot Study 73
Prevalence and cardiovascular outcomes of left ventricular hypertrabeculation in children 73
Naxos Disease and Related Cardio-Cutaneous Syndromes 71
Totale 11.083
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.985
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.985
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215 0 0 0 0 0 0 0 0 0 0 0 5
2021/2022340 10 3 2 18 91 12 11 28 9 25 21 110
2022/2023703 76 54 8 38 82 36 4 42 324 5 19 15
2023/2024487 20 13 13 29 106 112 13 42 9 12 24 94
2024/20251.958 8 12 4 39 332 268 237 179 309 230 195 145
2025/20269.004 450 511 432 347 699 4.608 616 438 344 263 181 115
Totale 12.693